Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Miscellaneous | 10.87% |
| 5 | Consumer Discretionary | 10.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZVO
2001
DELISTED
Zovio Inc. Common Stock
ZVO
| $2.68M | ﹤0.01% |
382,204
-627,661
| -62% | -$5.36M |
|
|
BRSL
2002
CALL
Brightstar Lottery PLC
BRSL
$2.07B
| $2.68M | ﹤0.01% |
183,000
-726,500
| -80% | -$12M |
|
|
MBFI
2003
DELISTED
MB Financial Corp
MBFI
| $2.68M | ﹤0.01% |
+67,553
| New | +$2.94M |
|
|
JOYY
2004
JOYY Inc
JOYY
$3.66B
| $2.67M | ﹤0.01% |
44,692
+20,906
| +88% | +$1.36M |
|
2005
PUT
Corcept Therapeutics
CORT
$12.6B
| $2.67M | ﹤0.01% |
200,000
| – | – |
|
|
CMCM
2006
Cheetah Mobile
CMCM
$92.8M
| $2.66M | ﹤0.01% |
87,061
+74,547
| +596% | +$2.95M |
|
|
UROV
2007
DELISTED
Urovant Sciences Ltd.
UROV
| $2.66M | ﹤0.01% |
403,650
-91,114
| -18% | -$829K |
|
|
AVLR
2008
DELISTED
Avalara, Inc.
AVLR
| $2.66M | ﹤0.01% |
85,266
+64,819
| +317% | +$2.09M |
|
2009
VanEck Junior Gold Miners ETF
GDXJ
$9.92B
| $2.65M | ﹤0.01% |
+87,816
| New | +$2.47M |
|
2010
PUT
Seagate
STX
$192B
| $2.65M | ﹤0.01% |
68,600
-104,500
| -60% | -$4.4M |
|
2011
CEVA Inc
CEVA
$800M
| $2.63M | ﹤0.01% |
119,152
+112,170
| +1,607% | +$2.81M |
|
|
EPAY
2012
DELISTED
Bottomline Technologies Inc
EPAY
| $2.63M | ﹤0.01% |
54,771
-62,234
| -53% | -$3.6M |
|
2013
APA Corp
APA
$14.8B
| $2.63M | ﹤0.01% |
100,113
+11,141
| +13% | +$411K |
|
2014
InflaRx
IFRX
$335M
| $2.62M | ﹤0.01% |
72,153
+11,080
| +18% | +$341K |
|
2015
ICICI Bank
IBN
$107B
| $2.62M | ﹤0.01% |
254,583
+157,850
| +163% | +$1.49M |
|
2016
White Mountains Insurance
WTM
$5.08B
| $2.62M | ﹤0.01% |
3,050
-928
| -23% | -$827K |
|
|
COHR
2017
DELISTED
Coherent Inc
COHR
| $2.61M | ﹤0.01% |
+24,659
| New | +$3.17M |
|
2018
NetApp
NTAP
$37.4B
| $2.61M | ﹤0.01% |
43,680
-481,399
| -92% | -$34.6M |
|
|
MDCO
2019
DELISTED
Medicines Co
MDCO
| $2.6M | ﹤0.01% |
136,106
+120,523
| +773% | +$2.8M |
|
2020
Impinj
PI
$5.14B
| $2.6M | ﹤0.01% |
178,931
-81,043
| -31% | -$1.59M |
|
2021
Malibu Boats
MBUU
$566M
| $2.6M | ﹤0.01% |
74,784
-50,161
| -40% | -$2.2M |
|
2022
iShares Russell 2000 Value ETF
IWN
$14.7B
| $2.6M | ﹤0.01% |
24,153
+5,100
| +27% | +$614K |
|
|
MTOR
2023
DELISTED
MERITOR, Inc.
MTOR
| $2.59M | ﹤0.01% |
153,397
-714,628
| -82% | -$12.2M |
|
|
CIM
2024
Chimera Investment
CIM
$964M
| $2.58M | ﹤0.01% |
48,351
+17,419
| +56% | +$953K |
|
|
SHOE
2025
Shoe Station Group
SHOE
$376M
| $2.58M | ﹤0.01% |
154,006
-332,678
| -68% | -$6.17M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $2.35B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.